AB-1015

N/A

Report date: 2022/11/16 20:00:46

Base Information

Drug NameAB-1015
Drug Alias NameAB-1015
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionAnti-Mesothelin
TargetsMesothelin
Therapy Area/IndicationsOvarian NeoplasmsCarcinoma, Ovarian Epithelial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArsenal Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesArsenal Biosciences Inc
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsCarcinoma, Ovarian Epithelial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A